{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T17:15:21Z","timestamp":1777914921867,"version":"3.51.4"},"reference-count":20,"publisher":"SAGE Publications","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Palliative Medicine"],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Responding to an epidemic of opioid-related deaths, guidelines and laws have been implemented to promote safe opioid prescribing practices.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This study evaluates differences in screening practices and knowledge of laws between oncologists and cardiologists who prescribe opiates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Surveys regarding screening practices and knowledge of opioid prescribing laws were distributed in March 2017 to oncology and congestive heart failure (CHF) clinicians at the University of Virginia. Chi-square and Wilcoxon rank sum tests were used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Forty-six of 129 (35.6%) oncology providers and 7 of 14 (50%) CHF providers reported prescribing opiates in their clinic with usable survey results. The majority of oncology (65.22%) and cardiology (85.71%) providers report screening for substance abuse \u201cwhen indicated\u201d (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.053). Only 19.6% of oncologists reported always using the prescription monitoring program (PMP), while 71.43% of cardiologists reported using it always (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.014). Of the oncology providers, 66.67% report never using the urine drug screen (UDS), while 86.7% of cardiologists reported using it \u201cwhen indicated\u201d (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.0086). Up to 34.78% of the oncologists and 57.14% of the cardiologists reported of never screening the family members for misuse (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.317). Knowledge of laws was similar between groups, with 14.29% of cardiology and 17.39% of oncology providers reporting no knowledge of opioid prescribing laws (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.2869).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Routine screening for substance misuse risk was uncommon for both groups, but cardiology providers were more likely to use the PMP or UDS. Knowledge gaps regarding Virginia laws were noted in both groups. Improved education regarding best practices and laws, as well as programs to promote screening, is needed for all providers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/jpm.2018.0638","type":"journal-article","created":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T14:15:50Z","timestamp":1555942550000},"page":"1115-1119","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Screening for Opioid Misuse in the Nonhospitalized Seriously Ill Patient"],"prefix":"10.1177","volume":"22","author":[{"given":"Julie L.","family":"Mitchell","sequence":"first","affiliation":[{"name":"Division of Hospital Medicine, Department of Medicine, Emory Palliative Care Center, Emory University School of Medicine, Atlanta, Georgia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie J.","family":"Blackhall","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Geriatrics, and Palliative Care, Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua S.","family":"Barclay","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Geriatrics, and Palliative Care, Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2019,9,3]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm655051e1"},{"key":"e_1_3_2_3_2","unstructured":"Key Substance Use and Mental Health Indicators in the United States: Results from the 2016 National Survey on Drug Use and Health (HHS Publication No. SMA 17\u20135044 NSDUH Series H-52). https:\/\/www.samhsa.gov\/data. 2017. (Last accessed April 19 2018)."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm056"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)01310-0"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-010-0118-6"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-014-2167-6"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/SPC.0000000000000065"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cnur.2016.05.003"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2012.0263"},{"key":"e_1_3_2_11_2","unstructured":"Virginia Board of Medicine Laws and Regulations: https:\/\/www.dhp.virginia.gov\/medicine\/medicine_laws_regs.htm. 2017. (Last accessed March 15 17)."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1177\/1049909114531445"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.741"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2012.01327.x"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-017-3575-1"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2015.0335"},{"key":"e_1_3_2_17_2","unstructured":"National Comprehensive Cancer Network. Adult Cancer Pain (version 1.2018). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/pain.pdf. 2018. (Last accessed April 19 2018)."},{"key":"e_1_3_2_18_2","unstructured":"Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. https:\/\/www.samhsa.gov\/data. 2014. (Last accessed March 28 2017)."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2013.0120"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-002-0033-6"},{"key":"e_1_3_2_21_2","first-page":"71","article-title":"Identifying and assessing the risk of opioid abuse in patients with cancer: An integrative review","volume":"7","author":"Carmichael AN","year":"2016","unstructured":"Carmichael AN, , Morgan L, , Del Fabbro E. Identifying and assessing the risk of opioid abuse in patients with cancer: An integrative review. Subst Abuse Rehabil, 2016; 7:71\u201379.","journal-title":"Subst Abuse Rehabil"}],"container-title":["Journal of Palliative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/jpm.2018.0638","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jpm.2018.0638","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jpm.2018.0638","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:04:57Z","timestamp":1777655097000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/jpm.2018.0638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["10.1089\/jpm.2018.0638"],"URL":"https:\/\/doi.org\/10.1089\/jpm.2018.0638","relation":{},"ISSN":["1096-6218","1557-7740"],"issn-type":[{"value":"1096-6218","type":"print"},{"value":"1557-7740","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}